Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Bolli

Showing results (61-70 of 313) with videos related to

Pageof 32
Sort By:
Texas Heart Institute Journal|October 16, 2023
Repeated Intravenous Administration of Mesenchymal Stromal Cells Produces Cumulative Beneficial Effects in Chronic Ischemic CardiomyopathyXian-Liang Tang, Roberto Bolli
Current Opinion in Cardiology|May 25, 2022
Clinical trials of cell therapy for heart failure: recent results warrant continued researchRoberto Bolli, Xian-Liang Tang
Journal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitationDavid J Lefer, Roberto Bolli
Circulation Research|August 31, 2013
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsSantosh K Sanganalmath, Roberto Bolli
Basic Research in Cardiology|October 18, 2024
CAESAR lives on with IMPACT: bringing rigor and relevance to cardioprotection researchRoberto Bolli, Xian-Liang Tang
Current Treatment Options in Cardiovascular Medicine|June 7, 2014
Cardiac stem cell therapy for cardiac repairKyung U Hong, Roberto Bolli
Circulation Research|July 10, 2010
Circulation Research and human genetic studiesA J Marian, Roberto Bolli
Circulation|December 7, 2005
No pain, no gain: the useful function of anginaRoberto Bolli, Ahmed Abdel-Latif
Basic Research in Cardiology|November 11, 2022
New insights into cardioprotection, gained by adopting the CAESAR standards of rigorRoberto Bolli, Xian-Liang Tang
Journal of Molecular and Cellular Cardiology|November 18, 2005
The ubiquitous role of nitric oxide in cardioprotectionSteven P Jones, Roberto Bolli
Pageof 32

Showing results (61-70 of 313) with videos related to

Sort By:
Pageof 32
Texas Heart Institute Journal|October 16, 2023
Repeated Intravenous Administration of Mesenchymal Stromal Cells Produces Cumulative Beneficial Effects in Chronic Ischemic CardiomyopathyXian-Liang Tang, Roberto Bolli
Current Opinion in Cardiology|May 25, 2022
Clinical trials of cell therapy for heart failure: recent results warrant continued researchRoberto Bolli, Xian-Liang Tang
Journal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitationDavid J Lefer, Roberto Bolli
Circulation Research|August 31, 2013
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsSantosh K Sanganalmath, Roberto Bolli
Basic Research in Cardiology|October 18, 2024
CAESAR lives on with IMPACT: bringing rigor and relevance to cardioprotection researchRoberto Bolli, Xian-Liang Tang
Current Treatment Options in Cardiovascular Medicine|June 7, 2014
Cardiac stem cell therapy for cardiac repairKyung U Hong, Roberto Bolli
Circulation Research|July 10, 2010
Circulation Research and human genetic studiesA J Marian, Roberto Bolli
Circulation|December 7, 2005
No pain, no gain: the useful function of anginaRoberto Bolli, Ahmed Abdel-Latif
Basic Research in Cardiology|November 11, 2022
New insights into cardioprotection, gained by adopting the CAESAR standards of rigorRoberto Bolli, Xian-Liang Tang
Journal of Molecular and Cellular Cardiology|November 18, 2005
The ubiquitous role of nitric oxide in cardioprotectionSteven P Jones, Roberto Bolli
Pageof 32